Vivek Ramaswamy, born on August 9, 1985, in Cincinnati, Ohio, USA, is a biotech entrepreneur, investor, and political figure. He is the founder of Roivant Sciences and co-founder of Strive Asset Management, making him a prominent figure in both the biopharmaceutical and financial industries.
As of 2025, Vivek Ramaswamy’s net worth is estimated to be over $960 million, primarily accumulated from his biotech ventures, hedge fund investments, and financial business holdings. His wealth skyrocketed after founding Roivant Sciences, a company that specializes in acquiring and developing underutilized pharmaceutical patents.
In this article, we’ll explore Vivek Ramaswamy’s net worth, income sources, business career, political journey, personal life, and lesser-known facts. Keep reading to discover more about his financial success and career milestones.
Vivek Ramaswamy’s Net Worth and Income Sources
As of 2025, Vivek Ramaswamy’s estimated net worth is over $960 million, making him one of the wealthiest figures in both the biotech and finance sectors.
Breakdown of Vivek Ramaswamy’s Wealth
Ramaswamy’s fortune is primarily derived from his successful biotech and investment ventures, with key contributions from:
- Roivant Sciences – A biotech firm he founded in 2014, which focuses on acquiring and developing underutilized pharmaceutical patents.
- Strive Asset Management – A financial firm he co-founded in 2022, positioned as an “anti-woke” investment platform.
- Hedge Fund Investments – Prior to founding Roivant, he was a partner at QVT Financial, managing a biotech investment portfolio.
- Book Royalties & Speaking Engagements – As an author of best-selling books, including Woke, Inc. and Nation of Victims, Ramaswamy has earned significant revenue from book sales and public speaking.
Estimated Wealth Breakdown
| Category | Details |
|---|---|
| Net Worth (2025) | Over $960 million |
| Primary Income | Biotech & Pharma Investments |
| Roivant Sciences Holdings | Major shareholder in Roivant Sciences |
| Financial Ventures | Strive Asset Management, Hedge Fund |
| Annual Earnings | Estimated $50-$100 million |
With his continued influence in biotech, finance, and politics, Ramaswamy’s net worth is expected to keep growing in the coming years.
Vivek Ramaswamy’s Short Details
| Field | Details |
|---|---|
| Full Name | Vivek Ganapathy Ramaswamy |
| Profession | Entrepreneur, Investor, Politician |
| Date of Birth | August 9, 1985 |
| Age (2025) | 39 years old |
| Nationality | American |
| Height | 5 feet 7 inches (1.70 meters) |
| Weight | 154 pounds (70 kg) |
| Zodiac Sign | Leo |
Early Life and Business Career
Early Life & Education
Vivek Ramaswamy was born in Cincinnati, Ohio, to Indian Hindu immigrant parents from Kerala, India. His father, V. Ganapathy Ramaswamy, worked as an engineer and patent attorney at General Electric, while his mother, Geetha Ramaswamy, was a geriatric psychiatrist.
Ramaswamy excelled academically, graduating valedictorian from St. Xavier High School in 2003. He then attended Harvard University, where he earned a Bachelor’s degree in Biology (summa cum laude) in 2007. He later pursued a Juris Doctor (JD) at Yale Law School, graduating in 2013.
During his Harvard years, he developed an interest in finance and worked at Goldman Sachs as a summer intern. He was also known for performing libertarian-themed rap music under the stage name “Da Vek”.
Biotech and Financial Ventures
Roivant Sciences (2014 – Present)
In 2014, Ramaswamy founded Roivant Sciences, a biotech company focused on acquiring and developing underutilized pharmaceutical patents. The firm received $100 million in startup capital, including investments from hedge funds like QVT and D.E. Shaw.
Key Highlights:
- Raised $360 million for its Axovant Sciences subsidiary.
- In 2015, Axovant’s IPO reached $3 billion, making headlines.
- Partnered with SoftBank, securing a $1.1 billion investment in 2017.
- In 2019, sold a stake in five subsidiaries to Sumitomo Dainippon Pharma, earning him $175 million in personal capital gains.
Despite some failed drug trials, Roivant remains a major biotech player, with Ramaswamy still holding a 7.17% stake in the company.
Strive Asset Management (2022 – Present)
In 2022, Ramaswamy co-founded Strive Asset Management, branding it as an “anti-woke” investment firm. The company raised $20 million from investors, including Peter Thiel, JD Vance, and Bill Ackman.
Key Highlights:
- Launched the DRLL ETF, an energy sector investment fund.
- Advocated for removing ESG policies from corporate investments.
Political Career and Presidential Run
In 2023, Ramaswamy announced his candidacy for the 2024 Republican Presidential nomination. Running as a Trump-aligned conservative, he positioned himself as an “anti-woke” candidate.
Despite gaining traction in conservative circles, he finished fourth in the Iowa Caucuses and suspended his campaign in January 2024, endorsing Donald Trump.
Following the campaign, he was appointed to lead the Department of Government Efficiency (DOGE) alongside Elon Musk under the Trump administration. However, he is expected to step down and launch a campaign for Ohio Governor in 2026.
Family and Relationships
| Family Member | Relationship |
|---|---|
| Apoorva Tewari Ramaswamy | Wife (Married in 2015) |
| Children | Two Sons |
| V. Ganapathy Ramaswamy | Father (Engineer, Patent Attorney) |
| Geetha Ramaswamy | Mother (Geriatric Psychiatrist) |
| Shankar Ramaswamy | Brother (Biotech Entrepreneur) |
Ramaswamy is married to Dr. Apoorva Tewari Ramaswamy, a laryngologist and surgeon. They met at Yale University, where she was studying medicine while he pursued law. The couple has two sons.
Lesser-Known Facts About Vivek Ramaswamy
- His stage name as a rapper was “Da Vek”, and he performed Eminem covers at Harvard.
- He was a nationally ranked tennis player in high school.
- He was a libertarian-leaning student leader at Harvard Political Union.
- He interned at Goldman Sachs before entering biotech.
- His first company, Campus Venture Network, was sold in 2009.
- He remains one of the wealthiest figures in biotech and finance.
- He was appointed to Trump’s administration but is expected to run for Governor of Ohio.
- He donated to both Republicans and Democrats before his political career.
Conclusion
Vivek Ramaswamy is a biotech billionaire, investor, and political figure, with an estimated net worth exceeding $960 million. From founding Roivant Sciences to launching Strive Asset Management, he has built a highly successful financial empire. His political ambitions continue to evolve, with a potential Ohio gubernatorial run on the horizon. His wealth and influence make him one of the most talked-about entrepreneurs in the U.S. today.
